Quest Diagnostics Inc Interest Expense Operating
Quest Diagnostics Inc (DGX) reported Interest Expense Operating of $68.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseOperating · last filed 2026-07-23
- Quest Diagnostics Inc interest expense operating for the quarter ending 2026-06-30 was $68.00M, a 1.45% decline year-over-year.
- Quest Diagnostics Inc interest expense operating for the quarter ending 2026-03-31 was $65.00M, a 9.72% decline year-over-year.
- Quest Diagnostics Inc interest expense operating for the quarter ending 2025-12-31 was $67.00M, a 6.94% decline year-over-year.
- Quest Diagnostics Inc interest expense operating for the quarter ending 2025-09-30 was $69.00M, a 18.97% increase year-over-year.
- Quest Diagnostics Inc interest expense operating for fiscal 2025 was $277.00M, a 22.57% increase from fiscal 2024.
- Quest Diagnostics Inc interest expense operating for fiscal 2024 was $226.00M, a 38.65% increase from fiscal 2023.
- Quest Diagnostics Inc interest expense operating for fiscal 2023 was $163.00M, a 10.14% increase from fiscal 2022.
- Quest Diagnostics Inc interest expense operating for fiscal 2022 was $148.00M.
| Period end | Interest Expense Operating 3 month | Interest Expense Operating 6 month | Interest Expense Operating 9 month | Interest Expense Operating 12 month |
|---|---|---|---|---|
| 2026-06-30 | $68.00M 10-Q · filed 2026-07-23 | $133.00M 10-Q · filed 2026-07-23 | $200.00M derived: sum of 3 quarters · filed 2026-07-23 | $269.00M derived: sum of 4 quarters · filed 2026-07-23 |
| 2026-03-31 | $65.00M 10-Q · filed 2026-04-22 | $132.00M derived: sum of 2 quarters · filed 2026-04-22 | $201.00M derived: sum of 3 quarters · filed 2026-04-22 | $270.00M derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-12-31 | $67.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $136.00M derived: sum of 2 quarters · filed 2026-02-26 | $205.00M derived: sum of 3 quarters · filed 2026-07-23 | $277.00M 10-K · filed 2026-02-26 |
| 2025-09-30 | $69.00M 10-Q · filed 2025-10-21 | $138.00M derived: sum of 2 quarters · filed 2026-07-23 | $210.00M 10-Q · filed 2025-10-21 | $282.00M derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-06-30 | $69.00M 10-Q · filed 2026-07-23 | $141.00M 10-Q · filed 2026-07-23 | $213.00M derived: sum of 3 quarters · filed 2026-07-23 | $271.00M derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-03-31 | $72.00M 10-Q · filed 2026-04-22 | $144.00M derived: sum of 2 quarters · filed 2026-04-22 | $202.00M derived: sum of 3 quarters · filed 2026-04-22 | $249.00M derived: sum of 4 quarters · filed 2026-04-22 |
| 2024-12-31 | $72.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $130.00M derived: sum of 2 quarters · filed 2026-02-26 | $177.00M derived: sum of 3 quarters · filed 2026-02-26 | $226.00M 10-K · filed 2026-02-26 |
| 2024-09-30 | $58.00M 10-Q · filed 2025-10-21 | $105.00M derived: sum of 2 quarters · filed 2025-10-21 | $154.00M 10-Q · filed 2025-10-21 | $200.00M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $47.00M 10-Q · filed 2025-07-23 | $96.00M 10-Q · filed 2025-07-23 | $142.00M derived: sum of 3 quarters · filed 2026-02-26 | $183.00M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $49.00M 10-Q · filed 2025-04-23 | $95.00M derived: sum of 2 quarters · filed 2026-02-26 | $136.00M derived: sum of 3 quarters · filed 2026-02-26 | |
| 2023-12-31 | $46.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $87.00M derived: sum of 2 quarters · filed 2026-02-26 | $163.00M 10-K · filed 2026-02-26 | |
| 2023-09-30 | $41.00M 10-Q · filed 2024-10-23 | $117.00M 10-Q · filed 2024-10-23 | ||
| 2022-12-31 | $148.00M 10-K · filed 2025-02-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |